| Primary |
| Attention Deficit/hyperactivity Disorder |
56.9% |
| Depression |
12.1% |
| Narcolepsy |
6.2% |
| Psychomotor Hyperactivity |
5.0% |
| Disturbance In Attention |
2.9% |
| Insomnia |
2.4% |
| Anxiety |
1.6% |
| Sleep Disorder |
1.6% |
| Asthma |
1.3% |
| Pain |
1.3% |
| Diabetes Mellitus |
1.2% |
| Malaise |
1.1% |
| Depressed Mood |
1.0% |
| Depressive Symptom |
0.9% |
| Agitation |
0.8% |
| Epilepsy |
0.8% |
| Hypersomnia |
0.7% |
| Somnolence |
0.7% |
| Convulsion |
0.7% |
| Fatigue |
0.6% |
|
| Suicidal Ideation |
10.7% |
| Weight Decreased |
9.1% |
| Vomiting |
8.6% |
| Suicide Attempt |
7.2% |
| Tremor |
6.8% |
| Intentional Drug Misuse |
5.6% |
| Somnolence |
5.6% |
| Tachycardia |
5.1% |
| Overdose |
4.7% |
| Visual Impairment |
4.2% |
| Withdrawal Syndrome |
4.0% |
| Delirium |
3.7% |
| Drug Dependence |
3.3% |
| Suicidal Behaviour |
3.3% |
| Surgery |
3.3% |
| Weight Increased |
3.3% |
| Drug Ineffective |
3.0% |
| Death |
2.8% |
| Drug Exposure During Pregnancy |
2.8% |
| Epilepsy |
2.8% |
|
| Secondary |
| Attention Deficit/hyperactivity Disorder |
37.4% |
| Product Used For Unknown Indication |
14.9% |
| Depression |
9.9% |
| Drug Use For Unknown Indication |
9.9% |
| Narcolepsy |
4.5% |
| Anxiety |
2.8% |
| Psychomotor Hyperactivity |
2.6% |
| Pain |
2.2% |
| Bipolar Disorder |
1.8% |
| Disturbance In Attention |
1.7% |
| Ill-defined Disorder |
1.7% |
| Drug Exposure During Pregnancy |
1.5% |
| Sleep Disorder |
1.5% |
| Headache |
1.4% |
| Insomnia |
1.3% |
| Suicide Attempt |
1.1% |
| Disturbance In Social Behaviour |
1.1% |
| Conduct Disorder |
1.0% |
| Obsessive-compulsive Disorder |
0.9% |
| Agitation |
0.8% |
|
| Suicide Attempt |
11.8% |
| Weight Decreased |
9.4% |
| Tachycardia |
8.3% |
| Suicidal Ideation |
7.8% |
| Tremor |
6.2% |
| Somnolence |
5.9% |
| Withdrawal Syndrome |
5.6% |
| Weight Increased |
5.4% |
| Overdose |
4.8% |
| Vomiting |
4.6% |
| Drug Ineffective |
3.8% |
| Depression |
3.2% |
| Growth Retardation |
3.2% |
| Palpitations |
3.2% |
| Laceration |
2.9% |
| Myocardial Infarction |
2.9% |
| Psychotic Disorder |
2.9% |
| Sleep Disorder |
2.9% |
| Tic |
2.7% |
| Road Traffic Accident |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.9% |
| Drug Use For Unknown Indication |
12.0% |
| Depression |
11.3% |
| Attention Deficit/hyperactivity Disorder |
10.8% |
| Pain |
6.5% |
| Multiple Sclerosis |
5.1% |
| Insomnia |
5.1% |
| Anxiety |
3.9% |
| Bipolar Disorder |
3.9% |
| Narcolepsy |
3.1% |
| Fatigue |
2.8% |
| Hypertension |
2.6% |
| Cataplexy |
1.8% |
| Osteoporosis |
1.8% |
| Metastases To Bone |
1.7% |
| Sleep Disorder |
1.7% |
| Breast Cancer Metastatic |
1.7% |
| Multiple Myeloma |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Asthma |
1.7% |
|
| Weight Decreased |
11.4% |
| Weight Increased |
11.4% |
| Vomiting |
10.8% |
| Suicidal Ideation |
6.5% |
| Tremor |
5.3% |
| Somnolence |
5.2% |
| Nausea |
5.0% |
| Urinary Tract Infection |
4.9% |
| Drug Ineffective |
4.6% |
| Wrong Technique In Drug Usage Process |
4.3% |
| Rash |
3.7% |
| Headache |
3.5% |
| Pain |
3.5% |
| X-ray Abnormal |
3.3% |
| Suicide Attempt |
3.1% |
| Tachycardia |
2.8% |
| Fatigue |
2.7% |
| Product Quality Issue |
2.7% |
| Pulmonary Embolism |
2.7% |
| Vision Blurred |
2.7% |
|
| Interacting |
| Attention Deficit/hyperactivity Disorder |
38.1% |
| Convulsion |
9.5% |
| Depression |
9.5% |
| Smoking Cessation Therapy |
9.5% |
| Anxiety |
7.1% |
| Epilepsy |
4.8% |
| Fatigue |
4.8% |
| Hypertension |
4.8% |
| Postpartum Depression |
4.8% |
| Weight Control |
4.8% |
| Bipolar I Disorder |
2.4% |
|
| Respiratory Failure |
15.8% |
| Depression |
10.5% |
| Performance Status Decreased |
10.5% |
| Asthenia |
5.3% |
| Blood Creatine Phosphokinase Increased |
5.3% |
| Drug Interaction |
5.3% |
| Hypertension |
5.3% |
| Hypoaesthesia Oral |
5.3% |
| Intentional Drug Misuse |
5.3% |
| Mood Altered |
5.3% |
| Nausea |
5.3% |
| Serotonin Syndrome |
5.3% |
| Suicidal Ideation |
5.3% |
| Vomiting |
5.3% |
| Weight Decreased |
5.3% |
|
